Blockchain: Demand, Sales, Competitor and Forecast 2016 – 2021



Wise.Guy.

Blockchain Global Market 2016 Analysis and Forecast to 2021

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — Blockchain is a distributed ledger that is broadly discussed as a technology with huge innovation potential in all areas of financial services. To date, it is largely in the banking arena where blockchain use cases have been identified. However, blockchain technology also offers potential use cases for insurers, including innovating insurance products and services for growth, increasing effectiveness in fraud detection and pricing, and reducing administrative costs. In these application areas insurers could address some of the main challenges they are facing today – such as limited growth in mature markets, and cost reduction and regulatory pressures. The implementation of blockchain is a long-term project as it largely depends on network/system effects as well as on defining the regulatory conditions. In addition, before initial implementation steps are taken the benefits and limitations of the technology need to be fully addressed and understood. Considering all of this, and with many other financial services investigating its prospects, now is the best time for the insurance sector as a whole to further explore blockchain technology and its potential.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/648406-blockchain-an-emerging-digital-platform-for-insurers

Key Findings
• Blockchain ultimately provides access to secure, decentralized transactions, offering an improved basis for non-repudiation, governance, fraud prevention, financial and personal data, and reporting.
• Insurers see blockchain as an opportunity to integrate the ecosystems of trusted third parties to reduce the costs of their global platforms, improve customer and market reach, and develop new propositions.
• Blockchain provides more scope for insurers to maximize governance through improved data access, third-party controls, and more sophisticated management of the risks associated with their products and services, including resilience services and cyber insurance.

Synopsis
“Blockchain: An Emerging Digital Platform for Insurers” provides an in-depth analysis of blockchain technology and its potential application to the insurance industry. The report discusses how blockchain could revolutionize many of the long-standing systems and processes within general insurance, and how insurers could benefit from the characteristics offered by the tech. The brief also provides an overview of the limitations of blockchain and the challenges insurers are likely to face going forward.

Reasons to Buy
• Gain a detailed insight into the functions of blockchain technology. Discover how blockchain could be applied to general insurance, including the potential benefits and limitations.
• Be informed of the insurers investing in the technology and looking to develop blockchain-centric propositions in the coming years.

Table of Contents
EXECUTIVE SUMMARY
Blockchain is both an opportunity and a threat to insurance
Key findings
Critical success factors
THE IMPLICATIONS OF BLOCKCHAIN FOR INSURERS AND THE INDUSTRY
Introduction: what does blockchain technology mean for insurers?
Blockchain is a tagging system designed to prove the time, integrity, and identity of data
The evolution of blockchain is redefining certain aspects of the insurer business model
The evolution of blockchain presents new technical dynamics for insurers
Keyless signatures assist in the authentication and preservation of claims
Blockchain could provide a means to manage claims in a transparent manner
Insurers are looking beyond algorithms to establish a customer-focused claims model
OPPORTUNITIES FOR INSURERS
There are three main areas of opportunity for insurers in the use of blockchain
Fraud detection and risk prevention are the primary solutions for the industry
Collaborating with payment systems developers would help expand market knowledge
Blockchain technology offers a new level of cyber resilience
Investments in digital tech are becoming more commonplace among insurers
AXA is considering the integration of blockchain technology into its business practices
Aviva has partnered with Plug and Play to help transform ideas into products
Blockchain’s potential presents the use case for innovative smart insurance contracts
THE OUTLOOK FOR BLOCKCHAIN AND THE NEXT STEPS FOR INSURERS
There are limitations insurers must consider before applying blockchain
Blockchain: An Emerging Digital Platform for Insurers
APPENDIX
Abbreviations and acronyms
Definitions
Big data
Methodology
Primary and secondary research

Access Report @ https://www.wiseguyreports.com/reports/648406-blockchain-an-emerging-digital-platform-for-insurers

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Brook Furniture Rental Recognized With Prestigious 2016 CAMME Award from the Chicagoland Apartment Association

Lake Forest, IL, November 9, 2016 – Brook Furniture Rental is pleased to announce they have been recognized with prestigious 2016 CAMME Award.

LAKE FOREST, ILLINOIS, USA, November 10, 2016 /EINPresswire.com/ — Lake Forest, IL, November 9, 2016 – Brook Furniture Rental is pleased to announce they have been recognized with a 2016 CAMME Award for Model,Two/Three Bedroom under $25,000, located at the AMLI Deerfield Apartments in Illinois. The 2016 Chicagoland Apartment Marketing and Management Excellence (CAMME) Awards honor and celebrate excellence in every facet of Chicagoland’s apartment industry. A product of the Chicagoland Apartment Association (CAA), the annual CAMME Awards celebrated its winners at a gala on November 3, at Chicago’s Navy Pier.

“Our members work tirelessly to serve residents throughout the thriving Chicagoland apartment community, and we are thrilled to have an evening where those efforts can be recognized and honored,” said Michael Mini, executive vice president of the CAA. “This year’s winners represent the best of the best in the industry who go above and beyond—and have a lasting impact on their community.”

The CAMME Award category #54 given to Brook Furniture Rental was for a property who spent less than $25,000 to set up their model. Judging was based on a number of criteria's including: furniture placement and scale, textures, use of color and accessories as well as complimenting the intended market.

"Brook Furniture Rental takes great pride in not only the quality and style of our furnishings but in how we help our community partners create truly beautiful models that assist in the marketing rental process," said Bob Crawford, President, and CEO of Brook Furniture Rental. "We are honored to earn this recognition from our industry peers and to be a part of this prestigious group. We would like to thank CAA for this award and our partner AMLI Deerfield for giving us the opportunity to work with them to create such an outstanding model."

The model at AMLI Deerfield was also one of the top picks for the first annual Brook Best Dressed Awards selected out of 37 properties to appear in the Brook Calendar 2016.

“The CAMME Awards remind me of how honored I am to lead an association full of members who work so hard to provide great living experiences for their residents,” said Steve Rappin, CAA board president. “The Chicagoland Apartment Association represents companies ranging from owners of two-flats to the largest publicly traded real estate investment trusts—the awards earned this evening truly reflect a level of excellence in our industry.”

For a complete list of 2016 CAMME Award winners, please visit www.cammeawards.com.

About Brook Furniture Rental Inc.
Brook Furniture Rental, Inc. is a privately held furniture rental company headquartered in Lake Forest, IL having multiple locations across America. Its distribution centers are capable of serving approximately 70% of the U.S. population base. The company specializes in servicing the furniture rental needs of residents and businesses that are in a state of transition. These clients are serviced directly through the company's website or referred by various business partners. Currently, the company holds an industry-leading position in terms of on-time delivery and pick up measurement.

CONTACT:
Brook Furniture Rental Inc.
Terry McCloud
tmccloud@bfr.com
847.810.4052

About the Chicagoland Apartment Association
The Chicagoland Apartment Association (CAA) is “The Recognized Voice for the Multifamily Rental Housing Industry,” and represents more than 6,000 apartment professionals who own and/or manage over 180,000 market rate and affordable rental units in approximately 900 apartment buildings in the Chicagoland region. CAA provides professional development and networking opportunities to apartment industry professionals and advocates on their behalf at the state and local government level.

Terry McCloud
Brook Furniture Rental
847.810.4052
email us here

Source: PR

Open API Banking: Strategies, Service and Forecast 2016 – 2021



Wise.Guy.

Open API Banking Global Market 2016 Analysis and Forecast to 2021

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — Summary
Regulatory and technological developments are pushing banks in Europe and the UK to open up access to their systems and data via the use of application programming interfaces (APIs). If banks embrace the concept, they will be able to become one-stop shops for the best products on the market, crowdsource the development of new services, and generate revenue by selling access to their data and capabilities.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/640604-open-api-banking-defining-of-open-banking

Key Findings
• Regulatory initiatives such as PSD2 in Europe and the Open Banking Standard in the UK are forcing banks to open up their systems to third parties, and this will hasten the rollout of open APIs.
• Starling Bank and N26 are among those using the bank as a marketplace approach. Here, banks transform themselves into portals, using their open APIs to allow third-party services to be accessed from within their own platforms.
• Fidor Bank is an exemplar of the bank as a service strategy. Startups and other entities that want to offer banking services to their customers can connect to Fidor Bank’s capabilities via its APIs and build their own services and user interface on top.
Synopsis
Open API Banking: Defining the Potential and Opportunities” explores the impact of open banking initiatives and assesses the various strategies that banks can employ. This report is based on findings from our Retail Banking Insight Survey, together with interviews with industry figures and secondary research.

The report offers insight into:
• The current state of open banking and open API initiatives in the UK, Europe, and further afield.
• The advantages and disadvantages associated with the main open API strategies banks can use.
• Advice and recommendations for how to effectively deploy an open API strategy.

Reasons to Buy
• Learn more about the distinct open API strategies a bank can deploy, together with the specific advantages and disadvantages associated with each approach.
• Gain an understanding of the opportunities – and the threats – that open APIs will create for banks.
• Discover more about how specific banks around the world are already using APIs, their rationale for doing so, and their experiences to date.

Table of Contents
EXECUTIVE SUMMARY
APIs have the potential to bring about an open banking revolution
Key findings
Critical success factors
DEFINING THE OPEN BANKING LANDSCAPE
Open banking will be the most important banking trend over the next few years
The free exchange of data will increase competition and benefit consumers
Consumers will benefit from access to enhanced services
Easier product comparisons
Safer use of account aggregation tools
Wider access to credit
Provision of enhanced PFM services
Consumers are put off account aggregation by security concerns
There is a reluctance to give external aggregators access to account information
Concerns about account aggregation are high among those who are the most favorable towards the concept
The use of APIs will address most consumer concerns
Several initiatives are pushing providers towards open banking
PSD is at the forefront of European efforts
The UK is pushing ahead with the creation of an OBS
The OBP in Germany has developed its own open API standard
US moves towards open banking are more limited
ALTERNATIVE OPEN BANKING STRATEGIES FOR BANKS
Bank as a marketplace
Table of Contents
Open API Banking: Defining the Potential and Opportunities
Page VFIA, Published September
Crédit Agricole’s CA Store offers customers a choice of in-house and external apps
Starling Bank will create a Marketplace Platform
N’s Financial Hub enables full integration of services from other fintechs
Assessment of the bank-as-a-marketplace strategy
Bank as a facilitator
BBVA aims to replicate the success of AWS with its API_Market
Capital One has launched the US’s first fully open banking platform
Monzo is encouraging developers to create bespoke apps based on its API
Assessment of the bank-as-a-facilitator strategy
Bank as a service
Fidor Bank offers a complete software-as-a-service solution for startups and non-banks
solarisBank operates exclusively as a banking service for fintechs
Silicon Valley Bank and Sutor Bank also offer banking as a service
Assessment of the bank-as-a-service strategy
OPPORTUNITIES AND THREATS FROM OPEN APIS
Opportunities
Banks can become aggregators for consumers with multiple relationships
Banks can boost customer acquisition and reduce attrition by becoming one-stop shops
Crowdsourcing of new products will let banks meet the needs of a fragmented market
Smaller banks can offer their customers access to a wider range of products
Integration of products from incubator and accelerator programs will be easier

Access Report @ https://www.wiseguyreports.com/reports/640604-open-api-banking-defining-of-open-banking

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Automotive Composites Market to Reach $6.491 billion with 7.92% CAGR Forecast to 2021

Automotive Composites Market 2016 Global Trends, Market Share, Industry Size, Growth, Opportunities, and Forecast to 2021

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — Summery

Automotive Composites Market is expected to reach a global market size of $6.491 billion by the end of forecast period, at a compound annual growth rate of 7.92% from 2016 to 2021. A composite material is made from two or more materials, resulting in superior properties and structural performance better than each of its constituents. This has led to a surge in demand for these materials across various industries. Automotive is one such industry which has embraced composites for various applications like powertrain, interior and exterior furnishing. These composites are being preferred over alloys in vehicles to reduce overall weight and improve performance. Chemical corrosion resistance is another major advantage of these composites augmenting the demand for composites in the automotive industry.

These composites also increase the versatility and durability of the vehicle without increasing its weight. Resistance to heat and external impact, low carbon dioxide emission superior fuel efficiency, improved appearance and safety among others are some major advantages of the composites in automobiles.
This report provides a comprehensive analysis of the Automotive Composites Market. The market size and forecast of the global, regional and various segments has been provided in US$ billion.

Request a sample report @ https://www.wiseguyreports.com/sample-request/612553-automotive-composites-market-forecasts-from-2016-to-2021

Under market dynamics section, different drivers, restraints, current trends and opportunities which exist in the market have been discussed with a detailed analysis regarding the same. Market analysis has been provided with the help of Porter’s Five Forces model. The other major sub-sections under this section are supplier outlook, industry outlook, industry lifecycle analysis, and value chain.

Scenario analysis has also been provided considering the different factors affecting the Automotive Composites Market. Under this section, different scenarios like industry regulations and economic factors have been considered to provide market trends over the forecast period.

The report analyses the opportunities which exist in different regions has also been covered by the wide-ranging market segmentation and forecast for Americas, Europe Middle East and Africa and Asia Pacific regions.

Competition analysis section lists vendor market share, recent investments by some of the major players, deals and strategies adopted by them to increase their visibility in the market.

Complete report details @ https://www.wiseguyreports.com/reports/612553-automotive-composites-market-forecasts-from-2016-to-2021

Table of Contents

1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Dynamics

4.1. Market Overview and Segmentations
4.2. Drivers
4.3. Restraints
4.4. Opportunities
4.5. Supplier Outlook
4.6. Industry Outlook
4.7. Porter’s 5 Forces Analysis
4.8. Industry Value Chain Analysis
4.9. Scenario Analysis

5. Automotive Composites Market Forecast by Type (US$ billion)

5.1. Polymer Matrix

5.1.1. Glass Fiber
5.1.2. Natural Fiber
5.1.3. Carbon Fiber

5.2. Ceramic Matrix

5.3. Metal Matrix

6. Automotive Composites Market Forecast by Application (US$ billion)

6.1. Exterior
6.2. Interior
6.3. Structural
6.4. Chassis and Powertrain
6.5. Others

7. Automotive Composites Market Forecast by Geography (US$ billion)

7.1. Americas

7.1.1. US
7.1.2. Canada
7.1.3. Brazil
7.1.4. Mexico
7.1.5. Others

7.2. Europe Middle East and Africa

7.2.1. United Kingdom
7.2.2. Germany
7.2.3. France
7.2.4. Others

7.3. Asia Pacific

7.3.1. Japan
7.3.2. China
7.3.3. India
7.3.4. Russia
7.3.5. Australia
7.3.6. Others

8. Competitive Intelligence

8.1. Market Share of Key Players
8.2. Investment Analysis
8.3. Recent Deals
8.4. Strategies of Key Players

9. Company Profiles

9.1. Toray Industries
9.2. Cytec Industries
9.3. TenCate
9.4. Owens Corning
9.5. Johns Manville
9.6. Jushi Group
9.7. Nippon Sheet Glass
9.8. Ford
9.9. SGL Group
9.10. Volkswagen
9.11. Sabic

Get It Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=612553

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Actinium Pharmaceuticals Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Actinium Pharmaceuticals Treatment Pipeline Review H2 2016

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development by Actinium Pharmaceuticals, Inc., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/649760-actinium-pharmaceuticals-inc-product-pipeline-review-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the pipeline therapeutic landscape of Actinium Pharmaceuticals, Inc.
– The report provides overview of Actinium Pharmaceuticals, Inc. including its business description, key facts, and locations and subsidiaries
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report assesses Actinium Pharmaceuticals, Inc.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report features Actinium Pharmaceuticals, Inc.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy
– Evaluate Actinium Pharmaceuticals, Inc.’s strategic position with total access to detailed information on its product pipeline
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Actinium Pharmaceuticals, Inc.
– Identify potential new clients or partners in the target demographic
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Actinium Pharmaceuticals, Inc.’s pipeline depth and focus of pipeline therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Actinium Pharmaceuticals, Inc. Snapshot 5
Actinium Pharmaceuticals, Inc. Overview 5
Key Information 5
Key Facts 5
Actinium Pharmaceuticals, Inc. – Research and Development Overview 6
Key Therapeutic Areas 6
Actinium Pharmaceuticals, Inc. – Pipeline Review 10
Pipeline Products by Stage of Development 10
Pipeline Products – Monotherapy 11
Actinium Pharmaceuticals, Inc. – Pipeline Products Glance 12
Actinium Pharmaceuticals, Inc. – Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Actinium Pharmaceuticals, Inc. – Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Actinium Pharmaceuticals, Inc. – Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Actinium Pharmaceuticals, Inc. – Drug Profiles 16
Iomab-B 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
Actimab-A 18
Product Description 18
Mechanism of Action 18
R&D Progress 18
BC-8Y90 20
Product Description 20
Mechanism of Action 20
R&D Progress 20
BC-8SA 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
Actimab-B 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
Actimab-Br 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
Actimab-C 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
Actimab-P 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Monoclonal Antibody Conjugate for Hematological Tumor and Oncology 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Monoclonal Antibody Conjugate for Oncology 27
Product Description 27
Mechanism of Action 27
R&D Progress 27
Actinium Pharmaceuticals, Inc. – Pipeline Analysis 28
Actinium Pharmaceuticals, Inc. – Pipeline Products by Target 28
Actinium Pharmaceuticals, Inc. – Pipeline Products by Route of Administration 29
Actinium Pharmaceuticals, Inc. – Pipeline Products by Molecule Type 30
Actinium Pharmaceuticals, Inc. – Pipeline Products by Mechanism of Action 31
Actinium Pharmaceuticals, Inc. – Recent Pipeline Updates 32
Actinium Pharmaceuticals, Inc. – Dormant Projects 41
Actinium Pharmaceuticals, Inc. – Discontinued Pipeline Products 42
Discontinued Pipeline Product Profiles 42
Bismab-A 42
Actinium Pharmaceuticals, Inc. – Locations And Subsidiaries 43
Head Office 43
Appendix 44
Methodology 44

Access Report @ https://www.wiseguyreports.com/reports/649760-actinium-pharmaceuticals-inc-product-pipeline-review-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Hair Loss & Growth Treatments and Products Market By Applications,Regions And Companies Market Research Report To 2021



Wise.Guy.

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ —

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/609092-global-hair-loss-growth-forecast-to-2021

Hair Loss & growth Treatments and Products are the products which is a way to treat hair loss and promote hair growth. (Including oil, Shampoos and Conditioners and medicine product like Vitamins and supplements).The date in this report don’t include the date of surgrical hair restoration which worldwide revenue is about 1.87 Billion USD in 2015

Scope of the Report:

This report focuses on the Hair Loss & Growth Treatments and Products in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Complete Report Details @ https://www.wiseguyreports.com/reports/609092-global-hair-loss-growth-forecast-to-2021

Market Segment by Manufacturers, this report covers
Procter & Gamble
L’Oreal
Unilever
Taisho
Henkel
Merck
Shiseido
Johnson & Johnson Consumer Inc.
Rohto
Lifes2Good
Gerolymatos International
Toppik
Nanogen
Oxford BioLabs Ltd.
Ultrax Labs
Avalon Natural Products
Bayer
Yanagiya
Pharma Medico
Kerafiber
Phyto
Keranique
DS Healthcare Group
EcoHerbs Global
Kaminomoto
Softto
Bawang
Zhang Guang 101

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America, Middle East and Africa

Market Segment by Type, covers
Shampoos and Conditioners
Medicine Product

Market Segment by Applications, can be divided into
Women
Men

Table of Contents

Global Hair Loss & Growth Treatments and Products Market by Manufacturers, Regions, Type and Application, Forecast to 2021

1 Market Overview
1.1 Hair Loss & Growth Treatments and Products Introduction
1.2 Market Analysis by Type
1.2.1 Shampoos and Conditioners
1.2.2 Medicine Product
1.3 Market Analysis by Applications
1.3.1 Women
1.3.2 Men
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA
1.4.1.2 Canada
1.4.1.3 Mexico
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany
1.4.2.2 France
1.4.2.3 UK
1.4.2.4 Russia
1.4.2.5 Italy
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China
1.4.3.2 Japan
1.4.3.3 Korea
1.4.3.4 India
1.4.3.5 Southeast Asia
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil
1.4.4.2 Egypt
1.4.4.3 Saudi Arabia
1.4.4.4 South Africa

2 Manufacturers Profiles
2.1 Procter & Gamble
2.1.1 Business Overview
2.1.2 Hair Loss & Growth Treatments and Products Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Procter & Gamble Hair Loss & Growth Treatments and Products Sales, Price, Revenue, Gross Margin and Market Share
2.2 L’Oreal
2.2.1 Business Overview
2.2.2 Hair Loss & Growth Treatments and Products Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 L’Oreal Hair Loss & Growth Treatments and Products Sales, Price, Revenue, Gross Margin and Market Share
2.3 Unilever
2.3.1 Business Overview
2.3.2 Hair Loss & Growth Treatments and Products Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Unilever Hair Loss & Growth Treatments and Products Sales, Price, Revenue, Gross Margin and Market Share
2.4 Taisho
2.4.1 Business Overview
2.4.2 Hair Loss & Growth Treatments and Products Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Taisho Hair Loss & Growth Treatments and Products Sales, Price, Revenue, Gross Margin and Market Share
2.5 Henkel
2.5.1 Business Overview
2.5.2 Hair Loss & Growth Treatments and Products Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2

……….

3 Global Hair Loss & Growth Treatments and Products Market Competition, by Manufacturer
3.1 Global Hair Loss & Growth Treatments and Products Sales and Market Share by Manufacturer
3.2 Global Hair Loss & Growth Treatments and Products Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Hair Loss & Growth Treatments and Products Manufacturer Market Share
3.3.2 Top 6 Hair Loss & Growth Treatments and Products Manufacturer Market Share
3.4 Market Competition Trend

4 Global Hair Loss & Growth Treatments and Products Market Analysis by Regions
4.1 Global Hair Loss & Growth Treatments and Products Sales, Revenue and Market Share by Regions
4.1.1 Global Hair Loss & Growth Treatments and Products Sales by Regions (2011-2016)
4.1.2 Global Hair Loss & Growth Treatments and Products Revenue by Regions (2011-2016)
4.2 North America Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
4.3 Europe Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
4.4 Asia-Pacific Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
4.5 South America Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
4.6 Middle East and Africa Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)

5 North America Hair Loss & Growth Treatments and Products by Countries
5.1 North America Hair Loss & Growth Treatments and Products Sales, Revenue and Market Share by Countries
5.1.1 North America Hair Loss & Growth Treatments and Products Sales by Countries (2011-2016)
5.1.2 North America Hair Loss & Growth Treatments and Products Revenue by Countries (2011-2016)
5.2 USA Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
5.3 Canada Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
5.4 Mexico Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)

6 Europe Hair Loss & Growth Treatments and Products by Countries
6.1 Europe Hair Loss & Growth Treatments and Products Sales, Revenue and Market Share by Countries
6.1.1 Europe Hair Loss & Growth Treatments and Products Sales by Countries (2011-2016)
6.1.2 Europe Hair Loss & Growth Treatments and Products Revenue by Countries (2011-2016)
6.2 Germany Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
6.3 UK Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
6.4 France Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
6.5 Russia Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)
6.6 Italy Hair Loss & Growth Treatments and Products Sales and Growth (2011-2016)

…..Continued

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=609092

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Wind Power: Market Size,Offshore and Forecast 2016 – 2021



Wise.Guy.

Wind Power Global Market 2016 Analysis and Forecast to 2021

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — The report provides a clear overview of and detailed insight into the global wind market. It provides data covering historic and forecast market size, average capital cost, installed capacity and generation for onshore and offshore wind globally, and in ten key wind power markets – China, India, Brazil, Canada, Turkey, UK, US, South Africa, Germany, and Japan. The report analyzes key market aspects which determine wind sector and provides information on average turbine size, GHG emission reductions, employment opportunities, homes powered, turbine market share, capacity share by capacity range and import – export in wind sector.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/644207-wind-power-market-update-analysis-to-2025

The report uses data and information sourced from proprietary databases, primary and secondary research, and in-house analysis by GlobalData’s team of industry experts.

Scope
The report includes –
– Wind market study at global level and at key country level, covering countries such as China, India, Brazil, Canada, Turkey, UK, US, South Africa, Germany, and Japan
– Historic and forecast data for cumulative and annual installed power capacity and power generation for onshore and offshore wind
– Market size and average capital cost data at country and global level
– Statistics related to average turbine size, GHG emission reductions, employment opportunities, homes powered, turbine import – export
– Turbine market share at country and global level

Reasons to buy
– Facilitate decision-making based on strong historic and forecast data for the wind power market
– Maximize potential in the growth of the wind power market
– Identify key partners and business-development avenues
– Respond to competitors’ business structure, strategy and prospects

Table of Contents

1 Table of Contents 5
1.1 List of Tables 10
1.2 List of Figures 11
2 Introduction 20
2.1 Wind Power, Definition 20
2.2 Wind Power, Technology Overview 20
2.3 Wind Turbine and Components 21
2.4 GlobalData Report Guidance 23
3 Global 24
3.1 Snapshot 24
3.2 Installed Capacity 24
3.2.1 Regional Share 28
3.2.2 Key Country Share 30
3.3 Average Turbine Size 32
3.4 Power Generation 34
3.5 Influences on Economy and Environment 36
3.6 Costs and Market Size 40
3.7 Manufacture and Trade 42
4 China 44
4.1 Snapshot 44
4.2 Installed Capacity 44
4.3 Average Turbine Size 49
4.4 Power Generation 50
4.5 Influences on Economy and Environment 51
4.6 Costs and Market Size 55
4.7 Manufacture and Trade 57
4.8 Grid Curtailment 62
4.9 Inner Mongolia still Leads among Provinces 63
4.10 Contracts by FIEs 64
4.11 Strong Policy Support 65
5 India 66
5.1 Snapshot 66
5.2 Installed Capacity 66
5.3 Average Turbine Size 74
5.4 Power Generation 75
5.5 Influences on Economy and Environment 77
5.6 Costs and Market Size 80
5.7 Manufacture and Trade 82
5.8 Repowering 88
5.9 T&D Issues and Curtailment 89
5.10 Finance and Infrastructure Barriers 90
5.11 Refreshed Government Interest in Promoting Renewable Energy 91
6 Brazil 92
6.1 Snapshot 92
6.2 Installed Capacity 92
6.3 Average Turbine Size 94
6.4 Power Generation 95
6.5 Influences on Economy and Environment 97
6.6 Costs and Market Size 101
6.7 Manufacture and Trade 102
6.8 Auctions 108
6.9 Developer-Friendly Policies Introduced in 2014 111
6.9.1 Resolution Number 462/2014 111
6.9.2 Grid Connection Rules 111
6.9.3 Tax Exemptions for Components 111
7 Canada 112
7.1 Snapshot 112
7.2 Installed Capacity 112
7.3 Average Turbine Size 114
7.4 Power Generation 115
7.5 Influences on Economy and Environment 117
7.6 Costs and Market Size 120
7.7 Manufacture and Trade 121
7.8 Provincial Policy Support 126
7.9 Alberta’s Market and Operational Framework for Wind 127
8 Turkey 130
8.1 Snapshot 130
8.2 Installed Capacity 130
8.3 Average Turbine Size 132
8.4 Power Generation 133
8.5 Influences on Economy and Environment 135
8.6 Costs and Market Size 137
8.7 Manufacture and Trade 138
8.8 Ege and Marmara Remain the Regions with Largest Installed Capacity 144
8.9 Feed-in Tariffs Provide Major Support for Wind Power Capacity Addition 145
8.10 Land Legislation that Supports Wind Power 145
8.11 Bureaucratic Bottlenecks Still an Issue 145
9 UK 147
9.1 Snapshot 147
9.2 Installed Capacity 147
9.3 Average Turbine Size 150
9.4 Power Generation 151
9.5 Influences on Economy and Environment 154
9.6 Costs and Market Size 158
9.7 Manufacture and Trade 160
9.8 Scotland and the Irish Sea Had the Largest Capacity Additions in 2015 166
9.9 FiT for Onshore Wind Farms/Plants 168
9.10 ROC and CfD 169
9.11 Impact of UK’s Withdrawal from the European Union 169
10 US 170
10.1 Snapshot 170
10.2 Installed Capacity 170
10.3 Average Turbine Size 175
10.4 Power Generation 177
10.5 Influences on Economy and Environment 179
10.6 Costs and Market Size 182
10.7 Manufacture and Trade 183
10.8 Clean Power Plan and PTC extension Give a Very Optimistic Outlook 189
11 South Africa 190
11.1 Snapshot 190
11.2 Installed Capacity 190
11.3 Average Turbine Size 192
11.4 Power Generation 193
11.5 Influences on Economy and Environment 195
11.6 Costs and Market Size 197

Access Report @ https://www.wiseguyreports.com/reports/644207-wind-power-market-update-analysis-to-2025

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Global Mobile Phone Case Market 2016 Share, Trend, Segmentation and Forecast to 2021

This report studies Mobile Phone Casings in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan

PUNE, MAHARASTRA, INDIA, November 11, 2016 /EINPresswire.com/ —

Summary

This report studies Mobile Phone Casings in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in global market, with production, price, revenue and market share for each manufacturer, covering
Foxconn
Catcher
INTOPS
Lite-on Mobile
Hi-P
Jabil Green Point
BYD
Nolato

Request a Sample Report @ https://www.wiseguyreports.com/sample-request/735841-global-mobile-phone-casings-market-research-report-2016

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Mobile Phone Casings in these regions, from 2011 to 2021 (forecast), like
North America
Europe
China
Japan
Korea
Taiwan

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into
Type I
Type II
Type III

Split by application, this report focuses on consumption, market share and growth rate of Mobile Phone Casings in each application, can be divided into
Application 1
Application 2
Application 3

At any Query @ https://www.wiseguyreports.com/enquiry/735841-global-mobile-phone-casings-market-research-report-2016

Table of Contents

Global Mobile Phone Casings Market Research Report 2016
1 Mobile Phone Casings Market Overview
1.1 Product Overview and Scope of Mobile Phone Casings
1.2 Mobile Phone Casings Segment by Type
1.2.1 Global Production Market Share of Mobile Phone Casings by Type in 2015
1.2.2 Type I
1.2.3 Type II
1.2.4 Type III
1.3 Mobile Phone Casings Segment by Application
1.3.1 Mobile Phone Casings Consumption Market Share by Application in 2015
1.3.2 Application 1
1.3.3 Application 2
1.3.4 Application 3
1.4 Mobile Phone Casings Market by Region
1.4.1 North America Status and Prospect (2011-2021)
1.4.2 Europe Status and Prospect (2011-2021)
1.4.3 China Status and Prospect (2011-2021)
1.4.4 Japan Status and Prospect (2011-2021)
1.4.5 Korea Status and Prospect (2011-2021)
1.4.6 Taiwan Status and Prospect (2011-2021)
1.5 Global Market Size (Value) of Mobile Phone Casings (2011-2021)

7 Global Mobile Phone Casings Manufacturers Profiles/Analysis
7.1 Foxconn
7.1.1 Company Basic Information, Manufacturing Base and Its Competitors
7.1.2 Mobile Phone Casings Product Type, Application and Specification
7.1.2.1 Type I
7.1.2.2 Type II
7.1.3 Foxconn Mobile Phone Casings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.1.4 Main Business/Business Overview
7.2 Catcher
7.2.1 Company Basic Information, Manufacturing Base and Its Competitors
7.2.2 Mobile Phone Casings Product Type, Application and Specification
7.2.2.1 Type I
7.2.2.2 Type II
7.2.3 Catcher Mobile Phone Casings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.2.4 Main Business/Business Overview
7.3 INTOPS
7.3.1 Company Basic Information, Manufacturing Base and Its Competitors
7.3.2 Mobile Phone Casings Product Type, Application and Specification
7.3.2.1 Type I
7.3.2.2 Type II
7.3.3 INTOPS Mobile Phone Casings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.3.4 Main Business/Business Overview
7.4 Lite-on Mobile
7.4.1 Company Basic Information, Manufacturing Base and Its Competitors
7.4.2 Mobile Phone Casings Product Type, Application and Specification
7.4.2.1 Type I
7.4.2.2 Type II
7.4.3 Lite-on Mobile Mobile Phone Casings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.4.4 Main Business/Business Overview
7.5 Hi-P
7.5.1 Company Basic Information, Manufacturing Base and Its Competitors
7.5.2 Mobile Phone Casings Product Type, Application and Specification
7.5.2.1 Type I
7.5.2.2 Type II
7.5.3 Hi-P Mobile Phone Casings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.5.4 Main Business/Business Overview
7.6 Jabil Green Point
7.6.1 Company Basic Information, Manufacturing Base and Its Competitors
7.6.2 Mobile Phone Casings Product Type, Application and Specification
7.6.2.1 Type I
7.6.2.2 Type II
7.6.3 Jabil Green Point Mobile Phone Casings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.6.4 Main Business/Business Overview
7.7 BYD
7.7.1 Company Basic Information, Manufacturing Base and Its Competitors
7.7.2 Mobile Phone Casings Product Type, Application and Specification
7.7.2.1 Type I
7.7.2.2 Type II
7.7.3 BYD Mobile Phone Casings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.7.4 Main Business/Business Overview
7.8 Nolato
7.8.1 Company Basic Information, Manufacturing Base and Its Competitors
7.8.2 Mobile Phone Casings Product Type, Application and Specification
7.8.2.1 Type I
7.8.2.2 Type II
7.8.3 Nolato Mobile Phone Casings Production, Revenue, Price and Gross Margin (2015 and 2016)
7.8.4 Main Business/Business Overview

Buy Now @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=735841

…..Continued

NORAH TRENT
Wise Guy Reports
+91 841 198 5042
email us here

Source: PR

Erosive Oral Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Erosive Oral Treatment Pipeline Review H2 2016

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — “Erosive Oral Lichen Planus Global Clinical Trials Review, H1, 2016" provides an overview of Erosive Oral Lichen Planus clinical trials scenario. This report provides top line data relating to the clinical trials on Erosive Oral Lichen Planus. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/403184-erosive-oral-lichen-planus-global-clinical-trials-review-h1-2016

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global clinical trials landscape
– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
– The Report provides enrollment trends for the past five years
– Report provides latest news for the past three months

Reasons to buy
– Assists in formulating key business strategies with regards to investment
– Helps in identifying prominent locations for conducting clinical trials which saves time and cost
– Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
– Supports understanding of trials count and enrollment trends by country in global therapeutics market
– Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
– Facilitates clinical trial assessment of the indication on a global, regional and country level

Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Clinical Trials by G7 Countries: Proportion of Erosive Oral Lichen Planus to Mouth And Dental Disorders Clinical Trials 13
Clinical Trials by Phase in G7 Countries 14
Clinical Trials in G7 Countries by Trial Status 15
Clinical Trials by E7 Countries: Proportion of Erosive Oral Lichen Planus to Mouth And Dental Disorders Clinical Trials 16
Clinical Trials by Phase in E7 Countries 17
Clinical Trials in E7 Countries by Trial Status 18
Clinical Trials by Phase 19
In Progress Trials by Phase 20
Clinical Trials by Trial Status 21
Clinical Trials by End Point Status 22
Subjects Recruited Over a Period of Time 23
Clinical Trials by Sponsor Type 24
Prominent Sponsors 25
Top Companies Participating in Erosive Oral Lichen Planus Therapeutics Clinical Trials 26
Prominent Drugs 27
Clinical Trial Profile Snapshots 28
Appendix 70
Abbreviations 70
Definitions 70
Research Methodology 71
Secondary Research 71

Access Report @ https://www.wiseguyreports.com/reports/403184-erosive-oral-lichen-planus-global-clinical-trials-review-h1-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR

Leiomyosarcoma Therapeutic and Overview Pipeline Review H2



Wise.Guy.

Leiomyosarcoma Treatment Pipeline Review H2 2016

PUNE, INDIA, November 11, 2016 /EINPresswire.com/ — The report provides comprehensive information on the therapeutics under development for Leiomyosarcoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Leiomyosarcoma and features dormant and discontinued projects.

Get Sample Report @ https://www.wiseguyreports.com/sample-request/643484-leiomyosarcoma-pipeline-review-h2-2016

Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indicationsDrug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Scope
– The report provides a snapshot of the global therapeutic landscape of Leiomyosarcoma
– The report reviews pipeline therapeutics for Leiomyosarcoma by companies and universities/research institutes based on information derived from company and industry-specific sources
– The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
– The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
– The report reviews key players involved Leiomyosarcoma therapeutics and enlists all their major and minor projects
– The report assesses Leiomyosarcoma therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
– The report summarizes all the dormant and discontinued pipeline projects
– The report reviews latest news related to pipeline therapeutics for Leiomyosarcoma

Reasons to buy
– Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
– Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
– Identify and understand important and diverse types of therapeutics under development for Leiomyosarcoma
– Identify potential new clients or partners in the target demographic
– Develop strategic initiatives by understanding the focus areas of leading companies
– Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
– Devise corrective measures for pipeline projects by understanding Leiomyosarcoma pipeline depth and focus of Indication therapeutics
– Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
– Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Leiomyosarcoma Overview 7
Therapeutics Development 8
Pipeline Products for Leiomyosarcoma – Overview 8
Pipeline Products for Leiomyosarcoma – Comparative Analysis 9
Leiomyosarcoma – Therapeutics under Development by Companies 10
Leiomyosarcoma – Therapeutics under Investigation by Universities/Institutes 11
Leiomyosarcoma – Pipeline Products Glance 12
Late Stage Products 12
Clinical Stage Products 13
Leiomyosarcoma – Products under Development by Companies 14
Leiomyosarcoma – Products under Investigation by Universities/Institutes 15
Leiomyosarcoma – Companies Involved in Therapeutics Development 16
Advenchen Laboratories, LLC 16
BeiGene, Ltd. 17
Cell Medica Limited 18
Karyopharm Therapeutics, Inc. 19
Merck & Co., Inc. 20
Millennium Pharmaceuticals Inc 21
Mirati Therapeutics Inc. 22
Novartis AG 23
Pfizer Inc. 24
Vicore Pharma AB 25
Leiomyosarcoma – Therapeutics Assessment 26
Assessment by Monotherapy Products 26
Assessment by Target 27
Assessment by Mechanism of Action 29
Assessment by Route of Administration 31
Assessment by Molecule Type 33
Drug Profiles 35
AL-3818 – Drug Profile 35
Product Description 35
Mechanism Of Action 35
R&D Progress 35
axitinib – Drug Profile 38
Product Description 38
Mechanism Of Action 38
R&D Progress 38
BGB-290 – Drug Profile 44
Product Description 44
Mechanism Of Action 44
R&D Progress 44
C-21 – Drug Profile 46
Product Description 46
Mechanism Of Action 46
R&D Progress 46
Cellular Immunotherapy to Target LMP-1 and LMP-2 for Oncology and Infectious Diseases – Drug Profile 48
Product Description 48
Mechanism Of Action 48
R&D Progress 48
CMD-003 – Drug Profile 49
Product Description 49
Mechanism Of Action 49
R&D Progress 49
everolimus – Drug Profile 51
Product Description 51
Mechanism Of Action 51
R&D Progress 51

Access Report @ https://www.wiseguyreports.com/reports/643484-leiomyosarcoma-pipeline-review-h2-2016

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Norah Trent
wiseguyreports
+1 646 845 9349 / +44 208 133 9349
email us here

Source: PR